Published: December 31, 2020 (upd.)

This result is based on in-hospital trials, so it does not yet take into account early ambulatory and prophylactic treatment. The authors of the review intend to include three more trials, due to be published sometime in January, before providing a final conclusion. At the end of his presentation, Dr Hill describes ivermectin as a potentially “transformational treatment”.

See alsoOverview of all covid-19 ivermectin studies (IVMMETA)